Hospira Healthcare Corporation v. Kennedy Trust for Rheumatology Research, 2018 FC 259

This document cites

• Mishan (E.) & Sons Inc. et al. v. Supertek Canada Inc. et al., (2015) 473 N.R. 221 (FCA)
• Teva Canada Ltd. v. Pfizer Canada Inc., 2016 FCA 161
• Amgen Canada Inc. et al. v. Apotex Inc. et al., 2015 FC 1261
• Eli Lilly Canada Inc. v. Mylan Pharmaceuticals ULC et al., 2016 FCA 119
• Novartis Pharmaceuticals Canada Inc. v. Cobalt Pharmaceuticals Co. et al., (2014) 459 N.R. 17 (FCA)



See all quotations

• Janssen Inc. et al. v. Teva Canada Ltd., [2016] F.T.R. Uned. 246 (FC)
• Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
• Wenzel Downhole Tools Ltd. et al. v. National-Oilwell Canada Ltd. et al., (2012) 443 N.R. 173 (FCA)
• Pfizer Canada Inc. et al. v. Novopharm Ltd. et al., (2012) 436 N.R. 299 (SCC)
• Amgen Canada Inc. et al. v. Apotex Inc. et al., 2016 FCA 196
• Bayer Inc. et al. v. Cobalt Pharmaceuticals Co., 2016 FC 1013
• Bayer Inc. et al. v. Fresenius Kabi Canada Ltd. et al., 2016 FC 581
• Pollard Banknote Ltd. v. BABN Technologies Corp. et al., 2016 FC 883
• Shire Canada Inc. v. Apotex Inc. et al., 2016 FC 382
• Uponor AB v. Heatlink Group Inc. et al., 2016 FC 320
• Janssen Inc. v. Celltrion Healthcare Co. et al., 2016 FC 651
• JAY-LOR International Inc. et al. v. Penta Farm Systems Ltd. et al., (2007) 313 F.T.R. 1 (FC)
• Bayer Inc. et al. v. Cobalt Pharmaceuticals Co. et al., (2015) 474 N.R. 311 (FCA)
• Halford v. Seed Hawk Inc., (2006) 353 N.R. 60 (FCA)
• R. v. Einarson (K.), (2004) 184 O.A.C. 176 (CA)
• Silver's Garage Ltd. v. Bridgewater (Town), (1970) 2 N.S.R.(2d) 474 (SCC)
• Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., (2007) 328 F.T.R. 41 (FC)
• AB Hassle et al. v. Canada (Minister of National Health and Welfare) et al., 2002 FCA 421
• Bayer AG et al. v. Novopharm Ltd. et al., 2006 FC 379
• Whirlpool Corp. et al. v. Camco Inc. et al., (2000) 263 N.R. 88 (SCC)
• Novopharm Ltd. v. Eli Lilly & Co., (2010) 376 F.T.R. 227 (FC)
• Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., (2007) 366 N.R. 347 (FCA)
• Procter & Gamble v. Can., 2004 FCA 393
• Free World Trust v. Électro Santé Inc. et al., (2000) 263 N.R. 150 (SCC)
• Weatherford Canada Ltd. et al. v. Corlac Inc. et al., (2011) 422 N.R. 49 (FCA)
• Merck-Frosst - Schering Pharma GP et al. v. Canada (Minister of Health) et al., 2010 FC 933
• Beloit Canada Ltd. v. Valmet Oy, (1986) 64 N.R. 287 (FCA)
• Sanofi-Aventis Canada Inc. et al. v. Novopharm Ltd. et al., (2007) 366 N.R. 231 (FCA)
• Monsanto Canada Inc. et al. v. Schmeiser et al., (2004) 320 N.R. 201 (SCC)
• New Brunswick (Minister of Health and Community Services) v. J.G. and D.V., (1999) 216 N.B.R.(2d) 25 (SCC)